【摘要】 本文分析堪萨斯36例肝细胞癌的生存情况。两例无癌存活23年9个月和16年,其余存活0至473天,队列半数生存期(chl)为94(21,162)天。生存与性别没有明显关系。与70年代相比,80年代生存无明显改进。高加索人种患者的chl为115天,长于黑人的27天(Z=1.97)。Ⅰ,Ⅱ期病人的chl为152天,长于Ⅲ期的44天(Z=1.99)。<45岁病人的chl为206天,是≥45岁病人的45天的4.60倍(Z=1.43)。更多还原

【Abstract】 An analysis of cohort half-life( chl) was used for evaluating 35 registered cases of hepatoceltular carcinoma from Kansas. Two of them had survived for 8670 and 5845 days without evidence of cancer respectively, the others for o to 473, and overall ch 1 was 94 (21, 162). The survival had no significant relation to sex and has not obviously improved in 1980S by contrast with 1970S. The chl of Caucasian patients, 115, was longer than that of Black patients, 27. (Z=1.97). The patients with stage I. II had a longer chl, 152, than those with stage III. 44 , (Z=1.99). Patients younger than 45 years of age had a greater survival (chl, 206 versus 45) than did older patients despite the difference was not significant enough (Z=1.43) .更多还原